Xphozah 10 Mg Tablet, Film Coated
Product Images NDC 73154-110
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Xphozah 10 Mg (NDC 73154-110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Ardelyx, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (Xphozah 02)
Image (Xphozah 03)
Chemical Structure (Xphozah 04)
Image (Xphozah 05)
Image (Xphozah 06)
Image (Xphozah 07)
Principal Display Panel (10 mg Tablet Bottle Label)
Principal Display Panel (10 mg Tablet Bottle Label)
Principal Display Panel (10 mg Tablet Bottle Label)
This text appears to be a description for a medication called XPHOZAH, specifically the professional sample of XPHOZAH in tablet form. The tablets contain 10 mg of the active ingredient called tenapanor (provided as 10.6 mg of tenapanor hydrochloride). The text includes instructions to dispense and store the medication, as well as precautions to protect it from moisture using a desiccant. It states that XPHOZAH is not for sale, but is available as a professional sample. The recommended dosage and additional prescribing information are not provided in this text. The text also includes information about the distributor, Ardelys, Inc., located in Waltham, MA, USA, and mentions a patent website for XPHOZAH. The text contains a lot number and expiration date, but the specific values are not readable in the .*
Principal Display Panel (20 mg Tablet Bottle Label)
Principal Display Panel (20 mg Tablet Bottle Label)
XPHOZAH is a medication in tablet form, containing tenapanor. The container should be kept away from moisture. It is a prescription-only medicine and should be stored between 20°C to 26°C (68°F to 79°F). The recommended dosage can be found in the Prescribing Information. This medication is produced by Ardelyx, Inc. in Waltham, MA, USA. The expiration date and lot number are also provided.*
Principal Display Panel (20 mg Tablet Bottle Label)
This is a description of a professional sample of a medication called XPHOZAH (tenapanor). It is not available for sale and is intended for prescription use only. The package contains 14 tablets, each containing the equivalent of 20 mg of tenapanor. The tablets are accompanied by a desiccant to protect them from moisture. It is important to keep this medication out of reach of children. The recommended storage temperature is between 20°C to 25°C (68°F to 77°F) with permitted excursions between 15°C to 30°C (59°F to 86°F). The prescribing information should be consulted for the recommended dosage. The product is distributed by Ardelys, Inc. located in Waltham, MA, USA. Additional patent information can be found at www.XPHOZAH-patents.com. The provided LOT number and expiration date should be used for tracking and ensuring the medication's freshness and efficacy.*
Principal Display Panel (30 mg Tablet Bottle Label)
Principal Display Panel (30 mg Tablet Bottle Label)
XPHOZAH is a medication in tablet form, with each tablet containing 30 mg of tenapanor, provided as 31.9 mg of tenapanor hydrochloride. It is important to dispense and store XPHOZAH in its original container, with the desiccant, to protect it from moisture. The recommended dosage and other pertinent information can be found in the Prescribing Information. XPHOZAH is distributed by Ardelyx, Inc. and should be stored at controlled room temperature. The GTIN (Global Trade Item Number) and lot number are also provided for reference.*
Principal Display Panel (30 mg Tablet Bottle Label)
This is a description for a professional sample medication called "YPHOZAH hydrochi". Each tablet contains the equivalent of 30mg of the active ingredient, tenapanor. It is important to keep this medication out of the reach of children and it is not for sale. The tablets should be stored at a temperature between 20°C to 25°C (66°F to 77°F), with permitted excursions between 15°C to 30°C (53°F to 86°F). The medication is distributed by Ardelyx, Inc. located in Waltham, MA 02451, USA. This medication is available by prescription only and for more information, the prescribing information should be consulted.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.